http://dailynews.yahoo.com/h/nm/20010601/hl/diarrhea_vaccine_1.html
CALCUTTA (Reuters) - A team of US and Indian scientists
hopes to start clinical trials next year on a vaccine for rotavirus, one of the
chief causes of diarrheal deaths in India, an official said on Friday.
“Clinical trials should hopefully start a year from now
after we have received approvals of both US and Indian authorities,” Charles Gardner,
science attache at the US embassy in India, told Reuters in Calcutta.
He said the “candidate vaccine,” a vaccine that is yet to
be clinically tested, had been developed as part of the Indo-US Vaccine Action
Programme that started in 1987 to develop vaccines for AIDS (news - web sites),
tuberculosis, malaria and rotavirus.
A rotavirus vaccine was pulled from the market in the US
in 1999 after it was linked to a rare type of bowel obstruction in babies. However, researchers continue to look for a
vaccine that is safe and effective for preventing the viral infection.
In the US, rotavirus is the number one cause of severe
diarrhea in infants. Rotavirus causes about 50,000 diarrhea-related deaths in India
every year, Gardner said.
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.